Affiliation:
1. I.M. Sechenov First Moscow State Medical University
Abstract
The authors discuss the action mechanisms of β-adrenoblockers (β-AB), as well as pharmacokinetics, pharmacodynamics, and drug interaction of a highly selective β-AB bisoprolol. The paper presents the data on bisoprolol effectiveness and safety in arterial hypertension, coronary heart disease, chronic heart failure, and their combination with other diseases.
Subject
Cardiology and Cardiovascular Medicine
Reference22 articles.
1. Klinicheskaya farmakologiya. Pod red. V.G.Kukesa, izdanie 4. Moskva, “GEOTAR-Media” 2008; 392-5.
2. Smith C, Teitler M. Beta-blocker selectivity at cloned human beta1 and beta2 — adrenergic receptors. Cardiovasc Drugs Ther 1999; 13: 123.
3. Diagnostika i lechenie arterial'noi gipertenzii. Zh Sistem gipert 2010; 3: 5-26.
4. Keim HJ. Behandlung der leichten bis mittelschweren essentiellen Hypertonie mit Bisoprolol. Therapiewoche 1988; 38: 3507.
5. Nakanishi T. Effect of bisoprolol hemifumarate on the diurnal variation of blood pressure in patients with essential hypertension. Current Ther Res 1992; 5: 779.